As innovations in cancer care technology accelerate progress and improve patient outcomes, ASCO Breakthrough will be held in Yokohama, Japan & Online from 3rd Aug to 5th Aug 2023, brings together oncology thought leaders, practicing clinicians, med-tech pioneers, novel drug developers, and research trailblazers at this can’t-miss oncology meeting in Asia for inspiration, collaboration and solutions. ARCE Therapeutics’ abstract “Preclinical development of ARD103, a CLL-1 CAR-T produced by a 3-day DashCAR® technology, for acute myeloid leukemia” had been accepted by 2023 ASCO Breakthrough meeting. The study result will be presented by poster on 8/3/2023 11:45AM-1:15PM (Japan Time)(GMT+9).
Meeting: 2023 ASCO Breakthrough
Time: 8/3/2023 am11:45 -- pm1:15 [GMT+9]
Type: Poster Session A
Location: Level 3, Room 302 | On Demand
Abstract Number: #119
2023年美國臨床腫瘤學會亞洲會議(ASCO in ASIA)訂於2023年8月3日至5日在日本橫濱舉行。隨著技術的創新加速癌症治療的進展並改善患者治療的效果，ASCO Breakthrough是一個匯聚了腫瘤學意見領袖、臨床醫生、醫療技術先驅、新藥開發人員和研究學者的亞洲腫瘤醫學會議，提供與會者尋求靈感、合作和解決方案。 承寶生技通過ASCO大會審查，將於今年會議期間發表以DashCAR®技術所開發出針對治療急性骨髓白血病的CLL-1 CAR-T細胞治療研發成果。相關研究結果將於日本時間8/3 11:45AM以海報形式於ASCO Breakthrough會議發表。